Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS ... NASDAQ (RTTNews.com) - Boston Scientific Corp. ( BSX ) said Monday that it has received U.S. Food and Drug Administration or FDA approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation ... Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus ... FDA approves next-generation EES BSX scores FDA device approval for drug-eluting stent for coronary artery ... |
